News Detail
New Delhi, 25 June 2024: The Department of Pharmaceuticals (DoP) has once again expanded the list of special invitees for its Committee for reforms in the pricing framework for drugs and medical devices, formed in March this year to include representatives from the largest pharma......
View Details
Source : Pharmabiz
DoP
AIDAN
NAT Health
IMA
AIOCD
Laghu Udhyog Bharti
MSF
IP Alliance
IDMA
OPPI
USISPF
MTaI
CII
USIBC
FICCI
AiMeD
FOPE
ADMI
BDMAI
Assocham
NPPA
Drugs (Control of Prices) Order
Kelkar Committee
PRDC
DPCRC
Pronab Sen Committee
NPPP
DPCO
2013
Related News
- Orchid Pharma partners with Cipla to launch antibiotic Cefepime-Enmetazobactam in India (28-06-2024)
- DCA Telangana seizes spurious drug Vertin Tabs, overpriced Itragril-200 Caps and 3 drugs for misleading claims (28-06-2024)
- Govt sanctions ₹700 crore for setting up pharma and med tech centres (28-06-2024)
- GB Nagar: Himachal drug makers booked for sub-standard medicines (28-06-2024)
- CDSCO cracks whip on drug manufacturing units over quality lapses (28-06-2024)
- Madras HC sets aside Ban on online Sale of Medicines (28-06-2024)
- DCA Telangana seized 3 overpriced medicines and Two with misleading claims (27-06-2024)
- Centre puts in abeyance order linking CGHS with ABHA (27-06-2024)
- AFDLHF raises alarm over fake websites exploiting food licence seekers (27-06-2024)
- US FDA recommends steps to improve diversity in clinical trials (27-06-2024)